IRadimed Corporation
IRMD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $73 | $66 | $53 | $42 |
| % Growth | 11.7% | 23% | 27.5% | – |
| Cost of Goods Sold | $17 | $15 | $12 | $10 |
| Gross Profit | $56 | $50 | $41 | $32 |
| % Margin | 76.9% | 76.5% | 77.4% | 76.6% |
| R&D Expenses | $3 | $3 | $2 | $2 |
| G&A Expenses | $16 | $15 | $11 | $10 |
| SG&A Expenses | $32 | $27 | $23 | $20 |
| Sales & Mktg Exp. | $16 | $12 | $13 | $11 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $34 | $30 | $26 | $22 |
| Operating Income | $22 | $20 | $16 | $10 |
| % Margin | 30% | 30.6% | 29.3% | 23.5% |
| Other Income/Exp. Net | $2 | $2 | $1 | $0 |
| Pre-Tax Income | $24 | $22 | $16 | $10 |
| Tax Expense | $5 | $5 | $3 | $1 |
| Net Income | $19 | $17 | $13 | $9 |
| % Margin | 26.3% | 26.2% | 24.1% | 22.3% |
| EPS | 1.52 | 1.36 | 1.02 | 0.76 |
| % Growth | 11.8% | 33.3% | 34.2% | – |
| EPS Diluted | 1.5 | 1.35 | 1.02 | 0.74 |
| Weighted Avg Shares Out | 13 | 13 | 13 | 12 |
| Weighted Avg Shares Out Dil | 13 | 13 | 13 | 13 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2 | $2 | $1 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | $23 | $21 | $16 | $11 |
| % Margin | 31.1% | 31.7% | 30.6% | 26.8% |